Global Image Guided Radiation Therapy Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 2.11 Billion |
 Market Size (Forecast Year) |
USD 4.88 Billion |
 CAGR |
% |
| Major Markets Players |
Global Image-Guided Radiation Therapy Market Segmentation, By Type (4D gating/4D RT, LINAC (Linear Accelerator), Portal Imaging, Soft-Tissue Imaging, Lung MRI, Simplifying Cardiac MRI, Simplifying MRI-Conditional Implant Scans, Silent MRI Scanning, and Others), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, and Others), Procedure (Intensity-modulation radiation therapy, 3D Conformal Radiation therapy, Stereotactic therapy, Proton beam therapy, Particle therapy), Devices (X-Ray CT, MRI, PET, and Others), End-Users (Hospitals, Smart Cancer Centers, Research Institutes, Independent Radiotherapy Centers, and Others) – Industry Trends and Forecast to 2032
Image-Guided Radiation Therapy Market Analysis
The image-guided radiation therapy (IGRT) market is experiencing significant growth driven by continuous advancements in imaging technologies. One of the key methods emerging is the integration of advanced imaging techniques such as Cone Beam Computed Tomography (CBCT) and Magnetic Resonance Imaging (MRI) into radiation therapy systems. These allow real-time imaging during treatment, enhancing precision and minimizing damage to surrounding healthy tissues.
In addition, there is a growing use of artificial intelligence (AI) and machine learning (ML) to analyze imaging data. AI assists in automating the process of image registration and alignment, improving efficiency and reducing human error. The introduction of adaptive radiotherapy (ART) systems, which dynamically adjust the treatment plan based on daily imaging feedback, is also contributing to market growth.
Furthermore, the development of hybrid imaging technologies that combine multiple modalities, such as MRI with PET or CT scans, provides superior soft tissue visualization, essential for complex tumor targeting. As these technologies evolve, IGRT is increasingly seen as essential in treating cancers with high precision, leading to the market's expansion in both developed and emerging regions.
Image-Guided Radiation Therapy Market Size
The global image-guided radiation therapy market size was valued at USD 2.11 billion in 2024 and is projected to reach USD 4.88 billion by 2032, with a CAGR of 11.05% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Image-Guided Radiation Therapy Market Trends
“Advancements in Image-Guided Radiation Therapy (IGRT) Technology”
A key trend driving the growth of the image-guided radiation therapy (IGRT) market is the integration of advanced imaging techniques with radiation therapy systems. The development of high-resolution imaging modalities such as cone-beam CT (CBCT) and MRI-guided radiation therapy is significantly improving the precision and effectiveness of treatments. These technologies help ensure accurate tumor targeting, reducing damage to surrounding healthy tissues. For instance, Elekta’s Unity MRI-Linac system integrates high-field MRI with radiation therapy, enabling real-time tumor tracking and treatment adaptation. This innovation is expanding the clinical applications of IGRT, driving its adoption across oncology centers, and contributing to the market's expansion globally
Report Scope and Image-Guided Radiation Therapy Market Segmentation
|
Attributes |
Image-Guided Radiation Therapy Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
General Electric Company (U.S.), Hitachi, Ltd. (Japan), Vision RT Ltd. (U.K.), XinRay Systems (U.S.), Siemens Healthcare GmbH (Germany), C-RAD (Sweden), Koninklijke Philips N.V. (Netherlands), TOSHIBA CORPORATION (Japan), VIEWRAY TECHNOLOGIES, INC. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), IBA Worldwide (Belgium), BD (U.S.), Isoray Inc. (U.S.), and Mevion Medical Systems (U.S.) |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Image-Guided Radiation Therapy Market Definition
Image-guided radiation therapy (IGRT) is an advanced technique in cancer treatment that uses real-time imaging to guide and monitor the delivery of radiation to tumors. This method ensures precise targeting of the tumor, minimizing exposure to surrounding healthy tissues. IGRT combines imaging technologies, such as CT scans, X-rays, or MRI, with radiation therapy, allowing for adjustments to be made during treatment based on tumor movement or changes in patient position. It enhances treatment accuracy, reduces side effects, and improves overall treatment outcomes by ensuring the radiation is delivered accurately to the tumor site throughout the therapy sessions.
Image-Guided Radiation Therapy Market Dynamics
Drivers
- Rising Cancer Incidence
Rising cancer incidence is a significant driver for the image-guided radiation therapy (IGRT) market. With cancer cases increasing worldwide, there is a growing need for advanced treatment options that offer precision and effectiveness. IGRT enables more accurate radiation delivery by using real-time imaging techniques, ensuring that radiation targets only the tumor while minimizing damage to healthy tissues. For instance, in 2020, the global cancer incidence reached 19.3 million, highlighting the urgent need for effective treatments. IGRT, used in treatment modalities such as stereotactic body radiation therapy (SBRT), has become essential in oncology centers, helping to improve patient outcomes and reduce side effects, thus driving the market’s growth.
- Rising Non-invasive Treatment Options
Image-guided radiation therapy (IGRT) is gaining traction due to its non-invasive nature, offering a less painful alternative to traditional surgeries. This appeal is particularly important in the treatment of cancers such as prostate, lung, and head and neck cancers, where precision radiation can target tumors without the need for invasive surgical procedures. For instance, IGRT is increasingly used in prostate cancer treatment to minimize damage to surrounding tissues, such as the bladder and rectum, enhancing patient comfort and recovery. Patients prefer IGRT due to reduced risk of infection, shorter recovery times, and the ability to maintain a higher quality of life, driving its adoption across healthcare providers worldwide.
Opportunities
- Expansion of Radiation Oncology Centers
The global expansion of radiation oncology centers is creating significant opportunities in the image-guided radiation therapy (IGRT) market. As healthcare facilities aim to provide advanced cancer treatment options, they are increasingly adopting IGRT to enhance precision and improve clinical outcomes. For instance, According to the American Cancer Society, in 2022, around 20 million new cancer cases were diagnosed, leading to 9.7 million deaths globally. As the number of cancer patients rises, the demand for advanced treatment modalities, such as image-guided radiotherapy, is growing. This technique allows for precise targeting of tumors, improving treatment efficacy while minimizing damage to surrounding healthy tissues, offering better outcomes for patients, thereby fostering IGRT adoption and driving market growth.
- Improved Treatment Outcomes
The precision of Image-Guided Radiation Therapy (IGRT) allows radiation to be delivered directly to the tumor, minimizing damage to surrounding healthy tissues. This precision leads to better treatment outcomes, such as enhanced tumor control and fewer side effects such as nausea, fatigue, and skin irritation. For instance, in prostate cancer treatment, IGRT helps target the tumor with high accuracy, reducing the risk of radiation affecting nearby organs such as the bladder and rectum. As a result, patients experience fewer complications and improved recovery times. This growing demand for more effective and less invasive treatments is creating significant market opportunities for IGRT technologies in oncology centers worldwide.
Restraints/Challenges
- Complexity of Operation
The complexity of operation in image-guided radiation therapy (IGRT) is a significant barrier to market growth. The advanced technology requires highly skilled professionals for proper usage and precise execution of treatments. This demand for specialized training and expertise can limit the widespread adoption of IGRT, especially in regions with a shortage of well-trained healthcare workers. As a result, healthcare facilities in these areas may struggle to implement IGRT systems effectively, hindering the overall market expansion. The need for continuous professional development and the high learning curve associated with IGRT further restricts its accessibility, particularly in low-resource settings, where the lack of skilled personnel is a critical challenge.
- Side Effects and Patient Sensitivity
Despite technological advancements, image-guided radiation therapy (IGRT) can cause several side effects that hinder its market growth. Patients may experience skin irritation, fatigue, or discomfort due to the radiation exposure. In some cases, the high precision required in IGRT can lead to minor tissue damage around the targeted area, resulting in additional complications. These side effects can be particularly concerning for patients with sensitive skin or underlying health conditions, limiting the therapy's attractiveness. In addition, the fear of adverse reactions may discourage some patients from opting for IGRT, especially when alternative treatment methods are available, further restricting its widespread adoption in certain patient demographics.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Image-Guided Radiation Therapy Market Scope
The market is segmented on the basis of type, application, procedure, devices, and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- 4D Gating/4D RT
- LINAC (Linear Accelerator)
- Portal Imaging
- Soft-Tissue Imaging
- Lung MRI
- Simplifying Cardiac MRI
- Simplifying MRI-Conditional Implant Scans
- Silent MRI Scanning
- Others
Application
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Others
Procedure
- Intensity-Modulation Radiation Therapy
- 3D Conformal Radiation therapy
- Stereotactic Therapy
- Proton Beam Therapy
- Particle Therapy
Devices
- X-Ray CT
- MRI
- PET
- Others
End-Users
- Hospitals
- Smart Cancer Centers
- Research Institutes
- Independent Radiotherapy Centers
- Others
Image-Guided Radiation Therapy Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, type, application, procedure, devices, and end-users as referenced above.
The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
North America is expected to dominate the image-guided radiation therapy market due to its advanced healthcare infrastructure, rapid adoption of cutting-edge radiation technologies, and significant technological advancements. In addition, the growing geriatric population and increasing cases of chronic diseases, such as cancer, further drive the demand for image-guided radiation therapies in the region.
Asia-Pacific is expected to witness the fastest growth in the image-guided radiation therapy market during the forecast period. This growth is driven by the rising prevalence of target diseases, an increasing geriatric population, and advancements in healthcare infrastructure. The region's growing demand for precise and effective treatment options fuels the market's expansion.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Image-Guided Radiation Therapy Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Image-Guided Radiation Therapy Market Leaders Operating in the Market Are:
- General Electric Company (U.S.)
- Hitachi, Ltd. (Japan)
- Vision RT Ltd. (U.K.)
- XinRay Systems (U.S.)
- Siemens Healthcare GmbH (Germany)
- C-RAD (Sweden)
- Koninklijke Philips N.V. (Netherlands)
- TOSHIBA CORPORATION (Japan)
- VIEWRAY TECHNOLOGIES, INC. (U.S.)
- Elekta AB (Sweden)
- Accuray Incorporated (U.S.)
- IBA Worldwide (Belgium)
- BD (U.S.)
- Isoray Inc. (U.S.)
- Mevion Medical Systems (U.S.)
Latest Developments in Image-Guided Radiation Therapy Market
- In October 2023, Hitachi, Ltd. delivered its first proton therapy system to the National Cancer Centre Singapore, marking the first proton therapy treatment in Southeast Asia, completed on 11 August 2023. This strategic launch is expected to enhance Hitachi's market presence, drive business revenue, and expand its customer base in the healthcare sector
- In May 2023, Philips expanded its mobile C-arm portfolio with the introduction of Zenition 10, a next-generation system designed to offer enhanced imaging capabilities for intraoperative guidance. This addition strengthens Philips' position in the surgical imaging market, providing healthcare professionals with advanced tools for improved patient outcomes during minimally invasive procedures
- In April 2023, GE HealthCare launched Pixxoscan, a new MRI contrast agent, expanding its portfolio with two leading macrocyclic molecules: Clariscan (gadoteric acid) and Pixxoscan (gadobutrol). This launch aims to offer advanced diagnostic capabilities, improve imaging precision, and enhance patient care, solidifying GE's position in the medical imaging and contrast agent market
- In June 2023, GE HealthCare announced plans to enhance its PET/MR capabilities with AIR technologies, aiming to increase diagnostic precision and simplify treatment evaluations. This development also focuses on improving patient comfort during scans, reinforcing GE's commitment to advancing imaging technologies and enhancing patient care within the growing diagnostic imaging market
- In September 2022, China's National Medical Products Administration (NMPA) approved ViewRay's MRIdian MRI-guided radiation therapy system for sale and use. This approval allows ViewRay to expand its footprint in the Chinese market, offering advanced cancer treatment solutions that integrate MRI and radiation therapy to improve precision and outcomes in cancer care
- In October 2020, Elekta launched the Elekta Harmony linear accelerator (linac), a new cancer treatment system designed to improve precision in radiation therapy. This strategic product introduction helps Elekta expand its cancer care offerings, increase its market share, and drive revenue growth in the rapidly evolving radiation therapy sector
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
